1. Home
  2. STNE vs SUPN Comparison

STNE vs SUPN Comparison

Compare STNE & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$15.11

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STNE
SUPN
Founded
2012
2005
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
STNE
SUPN
Price
$15.11
$51.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$19.19
$61.60
AVG Volume (30 Days)
4.2M
464.4K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$14.84
$22.70
Revenue Next Year
$6.04
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.95
$29.16
52 Week High
$19.95
$59.68

Technical Indicators

Market Signals
Indicator
STNE
SUPN
Relative Strength Index (RSI) 56.55 53.70
Support Level $14.36 $47.43
Resistance Level $15.93 $52.25
Average True Range (ATR) 0.66 1.56
MACD 0.20 0.04
Stochastic Oscillator 69.21 71.20

Price Performance

Historical Comparison
STNE
SUPN

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: